CONMED Corporation

Company Profile

CONMED Corporation had its IPO on 1987-07-23 under the ticker symbol CNMD.

The company operates in the Healthcare sector and Medical Devices industry. CONMED Corporation has a staff strength of 4,100 employees.

Stock update

Shares of CONMED Corporation opened at $96.02 at the start of the last trading session i.e. 2023-03-24.

The stocks traded within a range of $94.04 - $97.11, and closed at $97.

This is a +0.64% increase from the previous day's closing price.

A total volume of 335,314 shares were traded at the close of the day’s session.

In the last one week, shares of CONMED Corporation have increased by +5.84%.

CONMED Corporation's Key Ratios

CONMED Corporation has a market cap of $2.94 billion, indicating a price to book ratio of 3.877 and a price to sales ratio of 2.4615.

In the last 12-months CONMED Corporation’s revenue was $1.05 billion with a gross profit of $575.75 million and an EBITDA of $156.75 million. The EBITDA ratio measures CONMED Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, CONMED Corporation’s operating margin was 8.54% while its return on assets stood at 2.75% with a return of equity of -10.53%.

In Q4, CONMED Corporation’s quarterly earnings growth was a positive 16.4% while revenue growth was a negative 8.4%.

CONMED Corporation’s PE and PEG Ratio

Forward PE

27.027

Trailing PE

0

PEG

5.29

Its diluted EPS in the last 12-months stands at $-2.78 per share while it has a forward price to earnings multiple of 27.027 and a PEG multiple of 5.29. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CONMED Corporation’s profitability.

CONMED Corporation stock is trading at a EV to sales ratio of 3.538 and a EV to EBITDA ratio of 57.6193. Its price to sales ratio in the trailing 12-months stood at 2.4615.

CONMED Corporation stock pays annual dividends of $0.8 per share, indicating a yield of 0.89% and a payout ratio of 30.19%.

Balance sheet and cash flow metrics

Total Assets

$2.30 billion

Total Liabilities

$296.55 million

Operating Cash Flow

$-6318000.00

Capital Expenditure

$5.68 million

Dividend Payout Ratio

30.19%

CONMED Corporation ended 2023 with $2.30 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.30 billion while shareholder equity stood at $745.55 million.

CONMED Corporation ended 2023 with $66.73 million in deferred long-term liabilities, $296.55 million in other current liabilities, 313000.00 in common stock, $412.63 million in retained earnings and $815.43 million in goodwill. Its cash balance stood at $28.94 million and cash and short-term investments were $28.94 million. The company’s total short-term debt was $69,746,000 while long-term debt stood at $985.08 million.

CONMED Corporation’s total current assets stands at $581.23 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $191.35 million compared to accounts payable of $73.39 million and inventory worth $332.32 million.

In 2023, CONMED Corporation's operating cash flow was $-6318000.00 while its capital expenditure stood at $5.68 million.

Comparatively, CONMED Corporation paid $0.30 in dividends in 2023.

Other key metrics

Current Trading Price

$97

52-Week High

$154.1842

52-Week Low

$70.7802

Analyst Target Price

$112.17

CONMED Corporation stock is currently trading at $97 per share. It touched a 52-week high of $154.1842 and a 52-week low of $154.1842. Analysts tracking the stock have a 12-month average target price of $112.17.

Its 50-day moving average was $96.48 and 200-day moving average was $91.03 The short ratio stood at 9.17 indicating a short percent outstanding of 0%.

Around 408.7% of the company’s stock are held by insiders while 11976.4% are held by institutions.